Micafungina Reig Jofre

Micafungin Sodium, the active ingredient in Micafungina Reig Jofre, is an echinocandin presented as an intravenous solution for intravenous use. It treats invasive candidiasis, esophageal candidiasis and is used for prophylaxis of fungal infections in hematopoietic stem cell transplantation.

GNH USA supplies Micafungina Reig Jofre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Micafungina Reig Jofre is an echinocandin antifungal indicated for serious Candida infections and for prophylaxis in high‑risk patients. - Invasive candidiasis: eradicates bloodstream and deep‑tissue Candida infections. - Esophageal candidiasis: resolves mucosal infection and associated pain. - Prophylaxis in hematopoietic stem cell transplantation: prevents invasive fungal disease during periods of severe immunosuppression.

Micafungina Reig Jofre may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Fever: transient elevation of body temperature. - Nausea: mild to moderate upset stomach. - Vomiting: occasional episodes after infusion. - Headache: mild cranial discomfort. - Rash: skin erythema or pruritus. - Elevated liver enzymes: mild transaminase increase.

Serious or Rare Side Effects: - Hepatic failure: severe liver dysfunction requiring monitoring. - Anaphylaxis: acute, life‑threatening hypersensitivity reaction. - Severe infusion‑related reactions: hypotension, dyspnea, or chest discomfort. - Renal impairment: acute kidney injury in susceptible patients. - Severe neutropenia: marked reduction in neutrophil count. - Stevens‑Johnson syndrome: rare severe skin reaction.

Before initiating therapy, clinicians should assess patient‑specific risk factors and monitor organ function. - Liver function monitoring: check transaminases and bilirubin before and during treatment. - Renal function assessment: evaluate serum creatinine and adjust if necessary. - Hypersensitivity evaluation: screen for prior allergic reactions to echinocandins. - Caution in hepatic disease: use with heightened vigilance in patients with existing liver impairment. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Micafungina Reig Jofre has a limited interaction profile, but certain co‑medications may alter its exposure or increase toxicity.

Major Interactions (Avoid): - Rifampin or other strong enzyme inducers: may markedly reduce micafungin plasma concentrations. - Concurrent use of multiple echinocandins: increases risk of hepatotoxicity.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., fluconazole, voriconazole): may elevate liver enzymes when combined. - Immunosuppressants such as cyclosporine: potential increase in cyclosporine levels. - Anticoagulants like warfarin: monitor INR for possible alterations.